Ranjeev Krishana
Director/Board Member at BEIGENE, LTD.
Net worth: 571 503 $ as of 2024-05-30
Profile
Ranjeev Krishana is currently a Director at Sironax Ltd., Immunocore Holdings Plc, and BeiGene Ltd.
He previously worked as a Director at Pfizer Inc. from 2004 to 2007 and as a Senior Regional Director from 2008 to 2011.
He also served as the Head of International Investments at Baker Bros.
Advisors LP.
Additionally, he worked as a Consultant at Andersen Consulting (Minnesota) from 1995 to 1997 and as a Manager at Accenture LLC in 2001.
Mr. Krishana received his undergraduate degree from Brown University in 1995 and his graduate degree from Harvard University in 2001.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BEIGENE LTD
0.00% | 2024-06-04 | 50,492 ( 0.00% ) | 571 503 $ | 2024-05-30 |
Ranjeev Krishana active positions
| Companies | Position | Start |
|---|---|---|
| BEIGENE, LTD. | Director/Board Member | 2014-09-30 |
| IMMUNOCORE HOLDINGS PLC | Director/Board Member | 2024-05-27 |
Sironax Ltd.
 Sironax Ltd. Pharmaceuticals: MajorHealth Technology Sironax Ltd. is a clinical-stage biotechnology company located in Beijing, China. The Chinese company is dedicated to discovering and developing novel treatments for patients with age-related degenerative diseases. Sironax has built a diverse pipeline of multiple programs, focusing on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways, and neuroinflammation. Currently, Sironax is conducting early clinical studies with sir0365 and sir2446, in addition to ongoing preclinical research. | Director/Board Member | - |
Former positions of Ranjeev Krishana
| Companies | Position | End |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 2011-03-31 |
| PFIZER, INC. | Corporate Officer/Principal | 2006-12-31 |
Accenture LLC
 Accenture LLC Miscellaneous Commercial ServicesCommercial Services Accenture LLC operates as a global management consulting, technology services and outsourcing company. The company is headquartered in Reston, VA. | Corporate Officer/Principal | 2000-12-31 |
| Andersen Consulting (Minnesota) | Corporate Officer/Principal | 1996-12-31 |
Baker Bros. Advisors LP
 Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Portfolio Manager-Equities | - |
Training of Ranjeev Krishana
| Brown University | Undergraduate Degree |
| Harvard University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| BEIGENE, LTD. | Health Technology |
| IMMUNOCORE HOLDINGS PLC | Health Technology |
| Private companies | 4 |
|---|---|
| Andersen Consulting (Minnesota) | |
Accenture LLC
Accenture LLC Miscellaneous Commercial ServicesCommercial Services Accenture LLC operates as a global management consulting, technology services and outsourcing company. The company is headquartered in Reston, VA. | Commercial Services |
Baker Bros. Advisors LP
Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Finance |
Sironax Ltd.
Sironax Ltd. Pharmaceuticals: MajorHealth Technology Sironax Ltd. is a clinical-stage biotechnology company located in Beijing, China. The Chinese company is dedicated to discovering and developing novel treatments for patients with age-related degenerative diseases. Sironax has built a diverse pipeline of multiple programs, focusing on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways, and neuroinflammation. Currently, Sironax is conducting early clinical studies with sir0365 and sir2446, in addition to ongoing preclinical research. | Health Technology |
- Stock Market
- Insiders
- Ranjeev Krishana
